Health ❯Healthcare ❯Medical Research

Clinical Trials

Cancer Treatment Immunotherapy Alzheimer's Disease Stem Cell Therapy Hypertension Patient Outcomes Transplantation Studies Drug Development Innovative Treatments Oncology

Once-Monthly Subcutaneous Amivantamab Plus Lazertinib Shows High Response in Untreated EGFR‑Mutated NSCLC

Early results point to a more convenient frontline option with durability still unproven.

Jaypirca Delivers Significant PFS Benefit Over Chemoimmunotherapy in First-Line CLL/SLL

3-Week Radiotherapy Regimen Matches Survival, Cuts Severe Toxicity in Limited-Stage SCLC Trial

WCLC 2025: Combination Approaches Redraw EGFR-Mutant NSCLC Care

B7-H3 ADC Ifinatamab Deruxtecan Shows 48% Response in Relapsed ES-SCLC in Phase 2

Perioperative Nivolumab Preserves Quality of Life in Resectable NSCLC, WCLC 2025 Data Show

Baxdrostat Lowers Blood Pressure in Hard-to-Treat Patients in Phase III Trial

ESC Trials Back Shorter Antiplatelet Therapy for Selected MI Patients

AstraZeneca’s Baxdrostat Lowers Blood Pressure in Phase III, Setting Up 2025 Filings

Lancet Study Debuts Calculator to Match Hypertension Drugs to Needed BP Reductions

Major Trial Finds Sinus Surgery Outperforms Antibiotics for Chronic Rhinosinusitis

UC San Diego Reports First Anterior Cervical Surgery With Fully Personalized Implant

EU Grants Conditional Approval to Zemcelpro for Adults Needing Transplants Without a Matched Donor

China Reports First Pig-to-Human Lung Transplant Functioning for Nine Days

Confidence-Guided AI Cuts Mammogram Reading Burden 38% With No Loss in Detection

TIM‑3 Triplet Therapy Shows Promise in Immunotherapy‑Resistant Melanoma Models

Two-Dose Dalbavancin Regimen Noninferior to Standard Therapy for Complicated Staph Bacteremia

TAR-200 Clears Tumors in 82% of High-Risk Bladder Cancer Patients, Advances to FDA Priority Review

AI Use in Colonoscopies Linked to Decline in Clinician Detection Skills

Padcev and Keytruda Combo Extends Survival in Bladder Cancer Trial